Schedule 13D ownership disclosure

Castle Biosciences Inc

Security class unavailable · CUSIP: 14843C105

Event date: 2020-07-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,183,577
Percent of class
6.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-083177
Form type
SC 13D
Filer
CASTLE BIOSCIENCES INC
CIK
CIK 1447362
Filed
Jul 14, 2020
Reporting period
Jul 09, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub